How to read clinical trial results
Six checks behind a headline: participants, comparator, duration, outcomes, safety and source.
PEPTIDEATLAS / LIBRARY
Peptide research and COA documentation guides
How to read peptide COAs and batch records, compare primary sources and check clinical and regulatory status.
Start with the document, not the claim
This section is the entry point for people searching how to check research peptides, COA certificates, catalogue documentation and regulatory status. The goal is practical verification: what document you have, which batch it describes, who issued it and what it actually proves.
If you are comparing CagriSema, retatrutide, survodutide or cagrilintide, keep clinical trials, authorised medicines and catalogue research materials in separate categories. See the profiles: Retatrutide · Survodutide · Cagrilintide · CagriSema · Zenagamtide (amycretin) · MariTide (maridebart cafraglutide).
Verification guides
How to read a peptide certificate of analysis
Check batch identifiers, tests and results before interpreting a peptide supplier’s COA.
Peptide supplier documentation checklist
A practical way to separate documented supplier information from missing details and marketing claims.
Research peptides vs approved medicines
Why a molecule name, a trial result and a medicine authorisation answer different questions.
Three checks before opening a research catalogue
A quick, practical way to check a batch document, its method and the scope of a supplier claim.
Peptide research in 2026: five clinical programmes
Retatrutide, cagrilintide, survodutide, zenagamtide and MariTide: what their current clinical programmes do and do not show.
CagriSema in 2026: Phase 3 status and evidence
An evidence guide to CagriSema, its two components, current Phase 3 reporting and investigational status.